Successful DNA Tagging of Leather at One of the World’s Largest Tanneries
November 12 2019 - 9:03AM
Business Wire
Applied DNA Sciences to present results of
Pilot in Asia at Leather Compliance and Sustainability Conference
in NYC this week and the SATRA Sustainable Footwear Forum in
Wyndham Way, UK, 5 December
Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA,” “we,”
“our” or the “Company””), a leader in large-scale Polymerase Chain
Reaction (PCR)-based DNA manufacturing, announced today the
successful DNA tagging of leather at one of the world’s largest
tanneries based in Asia.
The work follows a successful research project undertaken within
the UK that demonstrated SigNature® DNA could be successfully used
to trace the hide of an animal from a farm to the product in a
store. Traceability is essential when supporting claims of
sustainability or the humane treatment of the animals. Further work
in commercial tanneries by the Applied DNA UK team took place
following the research project in other tanneries to identify the
most practical ways to use SigNature DNA technology in the leather
supply chain. We believe our research identified the most efficient
and cost-effective methods to apply DNA at specific points in the
leather-tanning process map.
The work recently carried out in Asia was focused on tagging
both suede and numerous polyurethane leather finishes in a variety
of different colors.
“The results are validation of previous work we carried out and
we now look forward to the opportunity to apply our technology for
the leather industry to help provide much needed traceability for
the various stakeholders,” said Dr. James Hayward, president and
CEO, Applied DNA. “We are pleased by the interest shown across the
leather industry in offering to leather supply chains.”
On November 13, 2019 at Tapestry headquarters in New York City,
MeiLin Wan, Vice President for Textiles at Applied DNA will be
speaking about our latest developments in DNA traceability at the
“Leather Compliance and Sustainability” conference hosted by
Eurofins/ BLC. The Company feels that effective traceability of
materials up the supply chain is the best way to manage
sustainability risk and mitigate against potential environmental
and social challenges.
On Thursday, 5 December 2019, Tony Benson, Managing Director of
EMEA for Applied DNA, will also present a Keynote at the “SATRA
Sustainable Footwear Forum” in Wyndham Way, UK.
Applied DNA has developed its CertainT® system for marking
leather through the leather value chain by using a DNA tag. This
molecular-based technology can help protect leather products,
brands, entire supply chains, and consumers from theft,
counterfeiting, fraud and diversion.
About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable
supply chain security, anti-counterfeiting and anti-theft
technology, product genotyping and pre-clinical nucleic acid-based
therapeutic drug candidates.
Applied DNA makes life real and safe by providing innovative,
molecular-based technology solutions and services that can help
protect products, brands, entire supply chains, and intellectual
property of companies, governments and consumers from theft,
counterfeiting, fraud and diversion.
Visit adnas.com for more information. Follow us on Twitter and
LinkedIn. Join our mailing list.
Common stock listed on NASDAQ under the symbol APDN, and
warrants are listed under the symbol APDNW.
Forward-Looking Statements
The statements made by Applied DNA in this press release may be
“forward-looking” in nature within the meaning of the Private
Securities Litigation Reform Act of 1995. Forward-looking
statements describe Applied DNA’s future plans, projections,
strategies and expectations, and are based on assumptions and
involve a number of risks and uncertainties, many of which are
beyond the control of Applied DNA. Actual results could differ
materially from those projected due to substantial doubt relating
to its ability to continue as a going concern, its history of net
losses, limited financial resources, limited market acceptance, its
ability to effectively implement its technology in the leather
industry, uncertainties relating to its ability to maintain its
NASDAQ listing after December 31, 2019 in light of delisting
notices received and its recent hearing, the possibility of failure
to make timely payment on its outstanding secured convertible notes
and resulting enforcement by noteholders of remedies on collateral
which includes substantially all of Applied DNA’s assets, its
ability to penetrate key markets, the uncertainties inherent in
research, development, and regulatory approval for Applied DNA’s or
its partners’ product candidates, shifting enforcement priorities
of U.S. federal laws relating to cannabis, and various other
factors detailed from time to time in Applied DNA’s SEC reports and
filings, including our Annual Report on Form 10-K filed on December
18, 2018, as amended, our subsequent quarterly reports on Form 10-Q
filed on February 7, 2019, May 9, 2019 and August 13, 2019, and
other reports we file with the SEC, which are available at
www.sec.gov. Applied DNA undertakes no obligation to update
publicly any forward-looking statements to reflect new information,
events or circumstances after the date hereof or to reflect the
occurrence of unanticipated events, unless otherwise required by
law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191112005678/en/
Investors: Sanjay M. Hurry, LHA Investor Relations,
212-838-3777, shurry@lhai.com Program: Tony Benson Managing
Director EMEA +44 7552 429341, tony.benson@adnas.com web:
www.adnas.com twitter: @APDN
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Apr 2023 to Apr 2024